PD-L1 status was not detected before and after neoadjuvant therapy, and whether the pathological tumour regression grade or expression of PD-L1 would have an impact on postoperative adjuvant treatment or helping predict prognosis could not be evaluated. The gene discussed is CD274; the disease is neoplasm.